Switch theme
Sign up to access all valuation multiples
Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
2008
9
LTM Revenue $0.8M
LTM EBITDA -$3.9M
$18.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Predilife has a last 12-month revenue of $0.8M and a last 12-month EBITDA of -$3.9M.
In the most recent fiscal year, Predilife achieved revenue of $0.3M and an EBITDA of -$4.1M.
Predilife expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Predilife valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.3M | $0.3M | XXX | XXX | XXX |
| Gross Profit | $0.1M | $0.3M | XXX | XXX | XXX |
| Gross Margin | 45% | 79% | XXX | XXX | XXX |
| EBITDA | -$3.7M | -$4.1M | XXX | XXX | XXX |
| EBITDA Margin | -1205% | -1201% | XXX | XXX | XXX |
| Net Profit | -$3.7M | -$3.9M | XXX | XXX | XXX |
| Net Margin | -1183% | -1147% | XXX | XXX | XXX |
| Net Debt | $2.5M | $3.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Predilife's stock price is EUR 4 (or $4).
Predilife has current market cap of EUR 14.0M (or $15.0M), and EV of EUR 17.1M (or $18.4M).
See Predilife trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18.4M | $15.0M | XXX | XXX | XXX | XXX | $-1.33 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Predilife has market cap of $15.0M and EV of $18.4M.
Predilife's trades at 21.6x LTM EV/Revenue multiple, and -4.8x LTM EBITDA.
Analysts estimate Predilife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Predilife and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $18.4M | XXX | XXX | XXX |
| EV/Revenue | 53.8x | XXX | XXX | XXX |
| EV/EBITDA | -4.5x | XXX | XXX | XXX |
| P/E | -3.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPredilife's NTM/LTM revenue growth is 51%
Predilife's revenue per employee for the last fiscal year averaged $38K, while opex per employee averaged $0.5M for the same period.
Over next 12 months, Predilife's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Predilife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Predilife and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -1201% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -1149% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $38K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1305% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Predilife acquired XXX companies to date.
Last acquisition by Predilife was XXXXXXXX, XXXXX XXXXX XXXXXX . Predilife acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Predilife founded? | Predilife was founded in 2008. |
| Where is Predilife headquartered? | Predilife is headquartered in France. |
| How many employees does Predilife have? | As of today, Predilife has 9 employees. |
| Is Predilife publicy listed? | Yes, Predilife is a public company listed on PAR. |
| What is the stock symbol of Predilife? | Predilife trades under ALPRE ticker. |
| When did Predilife go public? | Predilife went public in 2018. |
| Who are competitors of Predilife? | Similar companies to Predilife include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Predilife? | Predilife's current market cap is $15.0M |
| What is the current revenue of Predilife? | Predilife's last 12-month revenue is $0.8M. |
| What is the current EBITDA of Predilife? | Predilife's last 12-month EBITDA is -$3.9M. |
| What is the current EV/Revenue multiple of Predilife? | Current revenue multiple of Predilife is 21.6x. |
| What is the current EV/EBITDA multiple of Predilife? | Current EBITDA multiple of Predilife is -4.8x. |
| What is the current revenue growth of Predilife? | Predilife revenue growth between 2023 and 2024 was 10%. |
| Is Predilife profitable? | Yes, Predilife is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
